Bibliometric analysis of nanotechnology in spinal cord injury: current status and emerging frontiers

Frontiers in Pharmacology, 2024 · DOI: 10.3389/fphar.2024.1473599 · Published: December 11, 2024

Spinal Cord Injury Biomedical Research Methodology & Design

Simple Explanation

This study analyzes the use of nanotechnology for treating spinal cord injuries (SCI), which significantly affect physical and psychological health worldwide. The research looks at trends, influential studies, and the roles of different countries and institutions in this field, using data from the Web of Science Core Collection and tools like VOSviewer and CiteSpace. The findings highlight nanotechnology's potential in revolutionizing SCI treatment through targeted therapies and modulation of pathological processes like inflammation and apoptosis.

Study Duration

2002 to 2023

Participants

422 relevant publications

Evidence Level

Systematic Review

Key Findings

1
China and the United States are the leading countries in nanotechnology research for SCI, with China showing rapid growth in publications after 2019.
2
Inflammation, apoptosis, and nano-drug delivery are primary areas of focus in current research.
3
The study identifies key research clusters, including nanomaterials, cell-related therapies, therapeutic targets, and therapeutic goals.

Research Summary

This study provides a bibliometric analysis of nanotechnology in SCI research, highlighting global research output, collaborative networks, and influential works. The analysis identifies China, the United States, and Europe as major contributors, with research primarily focused on inflammation, apoptosis, and targeted drug delivery. The study underscores nanotechnology's potential to revolutionize SCI treatment through targeted therapies and emphasizes the need for continued innovation and interdisciplinary collaboration.

Practical Implications

Targeted Therapeutics Development

The research underscores the importance of developing nanotechnology-based therapies that can precisely target and modulate pathological processes in SCI.

Interdisciplinary Collaboration

The study emphasizes the need for continued interdisciplinary collaboration to foster innovation and overcome challenges in SCI treatment.

Geographic Focus

The analysis highlights the significant contributions from China, the United States, and Europe, suggesting opportunities for further collaboration and knowledge sharing.

Study Limitations

1
Only English-language documents were included
2
Some documents may have been unintentionally missed during the study selection process
3
Clinical trials are still rare

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury